Mucosal Advancement Flap Versus Ligation of the Intersphincteric Fistula Tract for Transsphincteric Fistula-in-Ano: A Comparative Study in a Tertiary Care Hospital

经括约肌肛瘘黏膜瓣推进术与括约肌间瘘管结扎术的比较研究:一家三级医院的比较研究

阅读:1

Abstract

Background and aim Transsphincteric fistula-in-ano (TPAF) is a common anorectal condition that poses significant surgical challenges due to the involvement of the external anal sphincter and the risk of postoperative incontinence. Sphincter-preserving procedures such as the mucosal advancement flap (MAF) and ligation of the intersphincteric fistula tract (LIFT) have become preferred alternatives; however, their comparative outcomes remain debated. This study aimed to compare postoperative outcomes between the MAF and LIFT procedures in patients with TPAF. Methods A prospective comparative study was conducted in the Department of General Surgery, Great Eastern Medical School and Hospital, Srikakulam, Andhra Pradesh, from June 2025 to September 2025. A total of 14 patients diagnosed with TPAF were randomized into two groups: Group A (MAF, n = 7) and Group B (LIFT, n = 7). Postoperative pain (Visual Analogue Scale (VAS) score), wound infection, time to complete healing, anal continence (Wexner score), and recurrence were assessed during a one-month follow-up. Results The mean age of the study population was 46.8 years, with a male-to-female ratio of 3:2. Postoperative pain at 48 hours was significantly lower in the LIFT group (VAS 3.1 ± 0.6) compared to the MAF group (VAS 4.8 ± 0.9, p = 0.02). Complete wound healing occurred faster with MAF (mean 18.6 ± 3.2 days) than with LIFT (21.4 ± 3.9 days, p = 0.05). Minor wound infection occurred in one patient (14.3%) from each group. No major incontinence was reported in either group, and no recurrence was observed at one month. Conclusions Both MAF and LIFT are safe and effective sphincter-preserving techniques for managing TPAF. LIFT offers reduced postoperative pain and shorter operative time, while MAF offers faster healing. Larger, multicenter trials with extended follow-up are warranted to establish long-term efficacy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。